Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial
New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds
Docetaxel As Adjuvant Therapy Shows Benefit Over Standard
QOL Of Anemic Patients Improved With Darbepoetin
UC Davis Study Finds Patients Need Practical Information
Clinical Trials Approved By NCI CTEP During May
Trending Stories
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Thomas B. Tomasi Jr., Roswell Park president and CEO from 1986 to 1996, dies at 97
An architect of today’s Roswell Park